搜索筛选:
搜索耗时2.2958秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
类      型:
[会议论文] 作者:Hong-Qing Zhuang, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Hong-Qing Zhuang, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objective: To explore the influence of image-guided tumor localization modality (Synchrony tracking versus Xsight spinebased localization) on the local efficacy of CyberKnife treatment in lung cancer...
[会议论文] 作者:Hong-qing Zhuang,Jun-jie Wang, 来源:北京大学医学部放射肿瘤学系成立大会暨北京大学第二届国际放射肿瘤学术论坛 年份:2012
  Tyrosine kinase inhibitors (TKI) has brought revolutionary change for the treatment of lung adenocarcinoma, and the theoretical basis is sufficient of whole...
[会议论文] 作者:Ping Wang,Yong-Chun Song,Zhi-Yong Yuan,Hong-Qing Zhuang,Feng-Tong Li, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Chun-Lei Liu,Hong-Qing Zhuang,Zhi-Yong Yuan,Mao-Bin Meng,Yong-Chun Song,Yang Dong,Feng-Tong Li, 来源:北京大学医学部放射肿瘤学系成立大会暨北京大学第二届国际放射肿瘤学术论坛 年份:2012
[会议论文] 作者:Chun-Lei Liu,Mao-Bin Meng,Hong-Qing Zhuang,Yong-Chun Song,Yang Dong,Feng-Tong Li,Zhi-Yong Yuan, 来源:北京大学医学部放射肿瘤学系成立大会暨北京大学第二届国际放射肿瘤学术论坛 年份:2012
Purpose This study was to evaluate the efficacy and toxicity of stereotactic body radiotherapy using Cyberknife in the treatment of patients with liver metastasis.Patients and Methods Between August 2...
[会议论文] 作者:Hong-Qing Zhuang,Bailin Zhang,Zhi-Yong Yuan,Jun Wang,Lu-Jun Zhao,Ping Wang,Junjie Wang, 来源:北京大学医学部放射肿瘤学系成立大会暨北京大学第二届国际放射肿瘤学术论坛 年份:2012
The optimal administration time when tyrosine kinase inhibitor (TKI) combined with radiotherapy is unclear until today.To investigate the efficacy of combining erlotinib with radiation in different tr...
[会议论文] 作者:Zhi-Yan Liu,Ping Wang,Kai Ji,Wei-Shuai Liu,Hong-Qing Zhuang,Zhi-Yong Yuan,Lin-Lin Gong,Lu-Jun Zhao, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Zhi-Yan Liu,Ping Wang,Kai Ji,Wei-Shuai Liu,Hong-Qing Zhuang,Zhi-Yong Yuan,Lin-Lin Gong,Lu-Jun Zhao, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objective: To evaluate the clinical efficacy and toxicity of simultaneous integrated boost intensity-modulated radiotherapy(SIB-IMRT) in patients with stage Ⅲ small cell lung cancer(SCLC).Methods: Fro...
相关搜索: